Skip to main content
. 2021 Jun 5;19:245. doi: 10.1186/s12967-021-02910-6

Fig. 2.

Fig. 2

Flow of clinical trials (interventional or non-interventional) integrating multi-omics approaches to identify disease endotypes, which enables biomarker-guided trials designs (adaptive or non-adaptive) and paves the way towards precision medicine approaches (tailoring treatments for personalised healthcare)